These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17147128)

  • 41. Adjuvant therapy of colon cancer.
    Sun W; Haller DG
    Semin Oncol; 2005 Feb; 32(1):95-102. PubMed ID: 15726511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irinotecan and high-dose fluorouracil/leucovorin for metastatic colorectal cancer.
    Douillard JY;
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):51-5. PubMed ID: 11200150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.
    Falcone A; Ricci S; Brunetti I; Pfanner E; Allegrini G; Barbara C; Crinò L; Benedetti G; Evangelista W; Fanchini L; Cortesi E; Picone V; Vitello S; Chiara S; Granetto C; Porcile G; Fioretto L; Orlandini C; Andreuccetti M; Masi G;
    J Clin Oncol; 2007 May; 25(13):1670-6. PubMed ID: 17470860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 45. A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer.
    Underhill C; Goldstein D; Gorbounova VA; Biakhov MY; Bazin IS; Granov DA; Hossain AM; Blatter J; Kaiser C; Ma D
    Oncology; 2007; 73(1-2):9-20. PubMed ID: 18334829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma.
    Gennatas C; Papaxoinis G; Michalaki V; Mouratidou D; Andreadis C; Tsavaris N; Pafiti A
    J Chemother; 2006 Oct; 18(5):538-44. PubMed ID: 17127232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.
    Grothey A; Sargent D; Goldberg RM; Schmoll HJ
    J Clin Oncol; 2004 Apr; 22(7):1209-14. PubMed ID: 15051767
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Application and recent research progress of irinotecan in treatment of advanced colorectal cancer].
    Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):718-9. PubMed ID: 17274384
    [No Abstract]   [Full Text] [Related]  

  • 49. Phase I/II study of irinotecan, 5-fluorouracil, and l-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer.
    Goto A; Yamada Y; Hosokawa A; Ura T; Arai T; Hamaguchi T; Muro K; Shimada Y; Shirao K
    Int J Clin Oncol; 2004 Oct; 9(5):364-8. PubMed ID: 15549585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer.
    Gholam D; Giacchetti S; Brézault-Bonnet C; Bouchahda M; Hauteville D; Adam R; Ducot B; Ghémard O; Kustlinger F; Jasmin C; Lévi F
    Oncologist; 2006; 11(10):1072-80. PubMed ID: 17110626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.
    Kabbinavar FF; Schulz J; McCleod M; Patel T; Hamm JT; Hecht JR; Mass R; Perrou B; Nelson B; Novotny WF
    J Clin Oncol; 2005 Jun; 23(16):3697-705. PubMed ID: 15738537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.
    Sahajpal A; Vollmer CM; Dixon E; Chan EK; Wei A; Cattral MS; Taylor BR; Grant DR; Greig PD; Gallinger S
    J Surg Oncol; 2007 Jan; 95(1):22-7. PubMed ID: 17066435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer.
    Pan CX; Loehrer P; Seitz D; Helft P; Juliar B; Ansari R; Pletcher W; Vinson J; Cheng L; Sweeney C
    Oncology; 2005; 69(1):63-70. PubMed ID: 16088234
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adjuvant therapy of colon cancer: a review.
    Hobday TJ; Erlichman C
    Clin Colorectal Cancer; 2002 Feb; 1(4):230-6. PubMed ID: 12450421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intergroup trial fails to demonstrate a benefit with the addition of irinotecan to bolus 5-fluorouracil/leucovorin in stage III colon cancer.
    Reddy GK
    Clin Colorectal Cancer; 2004 Nov; 4(4):230-2. PubMed ID: 15555203
    [No Abstract]   [Full Text] [Related]  

  • 56. Researchers urge caution with standard regimen for metastatic colorectal cancer.
    Traynor K
    Am J Health Syst Pharm; 2001 Jul; 58(13):1180. PubMed ID: 11449873
    [No Abstract]   [Full Text] [Related]  

  • 57. [Home chemotherapy and outpatient treatment for metastatic colorectal cancer].
    Sasaki K; Takasaka H; Nishikawa N; Yoshikawa T; Hirata K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():333-7. PubMed ID: 14574906
    [No Abstract]   [Full Text] [Related]  

  • 58. [Toxicities associated with chemotherapy in colorectal cancer].
    Ura T; Shirao K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():374-8. PubMed ID: 14574916
    [No Abstract]   [Full Text] [Related]  

  • 59. [Long- term remission survival with a case of rectal carcinoid tumor with metastasis in the soft tissue effectively treated with the combination therapy of irinotecan/5-fluorouracil/levofolinate followed by resection].
    Wada Y; Hirayama Y; Seki R; Konuma Y; Kohda K; Yoshida M; Nakamura Y; Obata M; Ando M
    Nihon Naika Gakkai Zasshi; 2007 Nov; 96(11):2513-5. PubMed ID: 18069303
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of colorectal carcinoma in adolescents and young adults with surgery, 5-fluorouracil/leucovorin/interferon-alpha 2a and radiation therapy.
    Pratt CB; Rao BN; Merchant TE; Shah A; Avery L; Cain A; Bodner S; Poquette C; Tan M
    Med Pediatr Oncol; 1999 Jun; 32(6):459-60. PubMed ID: 10358711
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.